Creatv provides LifeTracDx® liquid biopsies for cancer screening and diagnostics for all solid tumors. The tests are applicable to a) screening for pan cancer, b) determine residual disease, c) detect cancer recurrence, d) provide companion diagnostics without tissue, e) provide prognosis at any time, f) predict treatment response to new therapy within one treatment cycle, g) identify drug resistance, and h) provide copious unfragmented tumor DNA. We have established a CLIA-certified lab offering testing to patients and physicians, while also supporting cancer drug development for biopharma.